Shearman & Sterling advised Credit Suisse as sole book-running manager and I-Bankers as co-manager on SC Health Corporation’s, a special-purpose acquisition company, initial public offering of 15 million units at an offering price of $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant.

The company is ultimately controlled by SINCap, a Pan-Asia multi-asset professional investment firm with a differentiated investment approach and strategy focused on private investments in healthcare through its portfolio company, Fullerton Healthcare Corporation Limited. The company intends to focus its search for a target with operations or prospects in the healthcare sector in the Asia Pacific region, which may be a platform in the Asia pacific region or a global platform with a meaningful Asia Pacific growth thesis.

The Team